Effect of imipramine on ether à-go-go potassium channel (Kv1.10) expression in DU145 prostate cancer cells.

Sögüt, Fatma; Çömelekoglu, Ülkü; Dervisoglu, Hülya; Eroglu, Pelin; Yalin, Serap; Yilmaz, Necat Sakir

Sögüt, Fatma; Çömelekoglu, Ülkü; Dervisoglu, Hülya; Eroglu, Pelin; Yalin, Serap; Yilmaz, Necat Sakir.

Affiliation

Sögüt F; Department of First Aid and Emergency, Vocational School of Medical Services, Mersin University, Mersin, Turkey.
Çömelekoglu Ü; Department of Biophysics, Faculty of Medicine, Mersin University, Mersin, Turkey.
Dervisoglu H; Department of Histology and Embryology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Eroglu P; Department of Chemistry, Faculty of Science and Literature, Mersin University, Mersin, Turkey.
Yalin S; Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Yilmaz NS; Department of Histology and Embryology, Faculty of Medicine, Mersin University, Mersin, Turkey.

Andrologia ; 54(1): e14291, 2022 Feb.

Article de En | MEDLINE | ID: mdl-34729805

Sujet(s)
Mots clés

DU145 cells; Eag1 channels; imipramine; patch clamp; prostate cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Imipramine Limites: Humans / Male Langue: En Journal: Andrologia Année: 2022 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google